Free Trial
OTCMKTS:HYPMY

Hypermarcas (HYPMY) Stock Price, News & Analysis

Hypermarcas logo
$4.59 -0.27 (-5.46%)
As of 03:57 PM Eastern

About Hypermarcas Stock (OTCMKTS:HYPMY)

Key Stats

Today's Range
$4.59
$4.90
50-Day Range
$3.29
$5.02
52-Week Range
$2.64
$5.92
Volume
1,352 shs
Average Volume
17,076 shs
Market Capitalization
$2.91 billion
P/E Ratio
19.13
Dividend Yield
2.40%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, balance, Flavonid, histamin, NeoFresh, neolefrin, Neochemistry Vitamins, Neosorum, and Torsilax brand names; and consumer health products under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

Receive HYPMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hypermarcas and its competitors with MarketBeat's FREE daily newsletter.

HYPMY Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Hypera S.A. Reports 2024 Financial Performance
Hypera S.A. (HYPMY) Q4 2024 Earnings Call Transcript
Hypera: Short-Term Pain For Long-Term Gain
Hypera S.A. Reports Strategic Shift Amid Revenue Decline
See More Headlines

HYPMY Stock Analysis - Frequently Asked Questions

Hypermarcas' stock was trading at $3.06 on January 1st, 2025. Since then, HYPMY stock has increased by 50.0% and is now trading at $4.59.
View the best growth stocks for 2025 here
.

Hypermarcas (OTCMKTS:HYPMY) announced its quarterly earnings data on Wednesday, April, 23rd. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $184.34 million for the quarter. Hypermarcas had a net margin of 12.51% and a trailing twelve-month return on equity of 6.95%.

Shares of HYPMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/23/2025
Today
6/23/2025
Next Earnings (Estimated)
7/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:HYPMY
Fax
N/A
Employees
10,481
Year Founded
N/A

Profitability

Trailing P/E Ratio
20.10
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$248.62 million
Pretax Margin
2.82%

Debt

Sales & Book Value

Annual Sales
$1.38 billion
Cash Flow
$0.47 per share
Price / Cash Flow
10.27
Book Value
$3.54 per share
Price / Book
1.36

Miscellaneous

Free Float
N/A
Market Cap
$3.06 billion
Optionable
Not Optionable
Beta
0.79
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (OTCMKTS:HYPMY) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners